Nephros Inc. Files 8-K for Financial Results
Ticker: NEPH · Form: 8-K · Filed: Nov 13, 2024 · CIK: 1196298
| Field | Detail |
|---|---|
| Company | Nephros Inc (NEPH) |
| Form Type | 8-K |
| Filed Date | Nov 13, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
Related Tickers: NEPH
TL;DR
Nephros Inc. dropped its Q3 2024 8-K, check the exhibits for the numbers.
AI Summary
On November 7, 2024, Nephros Inc. reported its financial results for the period ending November 7, 2024. The filing details the company's operational and financial condition, including financial statements and exhibits. Specific financial figures and performance metrics are expected to be detailed within the accompanying exhibits.
Why It Matters
This filing provides investors and stakeholders with crucial updates on Nephros Inc.'s financial health and operational performance, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing and does not inherently introduce new risks.
Key Players & Entities
- Nephros Inc. (company) — Registrant
- November 7, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-32288 (identifier) — SEC File Number
- 13-3971809 (identifier) — IRS Employer Identification No.
- 380 Lackawanna Place, South Orange, New Jersey 07079 (address) — Address of principal executive offices
- (201) 343-5202 (phone_number) — Registrant's telephone number
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated November 7, 2024.
What is the company's full legal name as specified in its charter?
The exact name of the Registrant is NEPHROS, INC.
In which state was Nephros, Inc. incorporated?
Nephros, Inc. was incorporated in Delaware.
What is the SEC file number for Nephros, Inc.?
The SEC file number for Nephros, Inc. is 001-32288.
What is the primary business address of Nephros, Inc.?
The address of principal executive offices is 380 Lackawanna Place, South Orange, New Jersey 07079.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-11-13 16:15:42
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 par value NEPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 35KB
- ex99-1.htm (EX-99.1) — 88KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-045135.txt ( ) — 308KB
- neph-20241107.xsd (EX-101.SCH) — 3KB
- neph-20241107_lab.xml (EX-101.LAB) — 33KB
- neph-20241107_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Nephros, Inc. Dated: November 13, 2024 By: /s/ Judy Krandel Judy Krandel Chief Financial Officer